Clinical Trial: Colchicine for the Prevention of Post-Operative Atrial Fibrillation After Coronary Artery Bypass Grafting: A Single-Center, Strategy-Stratified, Randomized, Double-Blind, Placebo-Controlled Trial

U.S., May 29 -- ClinicalTrials.gov registry received information related to the study (NCT07611019) titled 'Colchicine for the Prevention of Post-Operative Atrial Fibrillation After Coronary Artery Bypass Grafting: A Single-Center, Strategy-Stratified, Randomized, Double-Blind, Placebo-Controlled Trial' on Feb. 24.

Brief Summary: Post-operative atrial fibrillation after coronary artery bypass grafting (CABG)

Study Start Date: June, 2026

Study Type: INTERVENTIONAL

Condition: Post-Operative Atrial Fibrillation After Coronary Artery Bypass Grafting (CABG)

Intervention: DRUG: Colchicine 0.5 MG oral tablet twice daily

Colchicine 0.5 mg administered orally twice daily beginning 3 days before surgery and continuing through postoperative da...